Cephalosporinases of Enterobacter cloacae and Citrobacter freundii were responsible for resistance to newercephalosporins such as cefotaximeand ceftazidime but not BMY-28142.
freundii, which produce chromosomal cephalosporinases, are more susceptible to BMY-28142than to other cephalosporins3~5). Recently, the emergence of cephalosporinase hyperproducing strains in these species which show resistance to newer cephalosporins, such as cefotaxime and ceftazidime, was reported6). On the resistance mechanismof cephalosporinase-high-producing strains against the newer cephalosporins, the theory of a "non-hydrolytic barrier" has been proposed7>8). BMY-28142 showshigher activity against these strains than other cephalosporins10. The relation of its low affinity, i.e. large Ki values, for cephalosporinases and its high activity was reported in comparison with ceftazidime^. However, how the low affinity leads less influence of cephalosporinase production on activity is still unclear. On the other hand, the importance of very slow hydrolysis by cephalosporinases was also reported10). In this paper, we attempted to clarify whyBMY-28142 is so effective and examined kinetically the interaction of drugs with cephalosporinases using cephalothin, ceftazidime and T Present address: Bristol-Myers Research Institute, 2-9-3 Shimomeguro, Meguro-ku, Tokyo 153, Japan.
cefotaxime in comparison with BMY-28142.
Materials and Methods
Antibiotics 87 BMY-28142was synthesized by Bristol-Myers Company in Syracuse, New York, and its sulfate salt (830^g/mg) was used in this study. Other antibiotics were donated by Shin Nihon Jitsugyo Co., Ltd., for ceftazidime, Hoechst Japan Limited for cefotaxime, Merck-Banyu Co., Ltd., for cefoxitin, Shionogi & Co., Ltd., for cephalothin.
Bacteria and Plasmid Escherichia coli MC4100 (F~AlacU169 araD139 rpsL relA thiA fibB)1^, E. coli MH1160 (MC4100 ompRl)12\ and E. coli MH760(MC4100 ompR2)13) were kindly donated by S. Mizushima (Nagoya University, Nagoya, Japan). MH1160lacks outer membrane proteins (Omp) F and C production.
MH760 lacks OmpC production and produces OmpF constitutively, while in the parent strain, MC4100, OmpFand OmpCproduction is osmo-regulated. The other strains were clinical isolates from several hospitals in Japan. Plasmid, pMS185, is a derivative of pACYC18414) carrying cephalosporinase gene from C. freundii GN346(not published).
Media
Sensitivity Disk agar-N (SDN), i.e. modified Mueller-Hinton agar, sensitivity test broth, medium B15), and nutrient agar with 1 % sodium citrate (pH 6.8) were used.
Susceptibility Test
Antibiotic susceptibility was tested by a serial 2-fold agar dilution method in SDN. Approximately 104 cfu were inoculated onto agar plates. The MICwas defined as the lowest concentration preventing visual growth of bacteria after incubation for 18~20 hours at 37°C.
Assay of Cephalosporinase
Cephalosporinase was assayed by a spectrophotometric method16), using a UV-265 spectrophotometer (Shimadzu). Anabsorbance change greater than 0.001 could be detected using this apparatus. Enzyme activity was determined at 30°C and pH 7.0 in 50 mMphosphate buffer, using cephalothin (100^m) as substrate, and was expressed in terms of mol hydrolyzed per second (Kat).
For the determination of cephalosporinase activity, a crude sonicate was used16). Kmand Vmax values were calculated from Lineweaver-Burk plots using least square method. To detect and determine hydrolysis rates of poor substrates, the concentration of cephalosporinases from E. cloacae GN7471and C. freundii GN7391used in the hydrolysis reaction mixture was 0.27 nKat/ml (E. cloacae) and 0.20 nKat/ml (C. freundii) for cephalothin and 803 nKat/ml (E. cloacae) and 160 nKat/ml (C. freundii) for the other cephalosporins. Determination of Inhibition Constant Ki values were calculated from initial hydrolysis rates of cephalothin (10~100^m) with and without a suitable concentration of inhibitor by Lineweaver-Burk plots using least square method. Pre-incubation of enzymewith inhibitor was not done to determine equilibrium constant of enzymeinhibitor (El) complex formation, because hydrolysis and inactivation were observed in other experiments.
Purification of Cephalosporinase
The cephalosporinase of E. cloacae GN7471and C. freundii GN7391were prepared by sonication and CM-Sephadex ion-exchange chromatography as previously described15>17). Further purification was not attempted, because the main active fraction of each enzymeafter CM-Sephadexchromatography showed single band in SDS-PAGE, more than 95 % purity, and high specificity (8.0^Kat/mg protein for E. cloacae, and 1.2 /^Kat/mg protein for C. freundii) comparable to those of previous preparation15>17). Protein was determined by the method of Lowry et a/.18), using bovine serum albumin as the standard. JAN. 1988 Determination of Binding to the Cephalosporinase from E. cloacae GN7471 The binding of cephalosporins to the cephalosporinase of E. cloacae GN7471at 20 [am of drug determined by a centrifugal ultrafiltration method19) that has been used for determination of serum protein binding. One volume of drug solution (final 20^m) in phosphate buffer (50 mM, pH 7.0) were mixed with same volumeof various concentrations of the cephalosporinase solution (final 0.271 1^Kat/ml) in the buffer. An enzyme-free ultrafiltrate of the mixture was obtained by centrifugation at 3,000xg for 20 minutes using a Centricon 10 (Amicon). The drug concentration in the filtrate were determined by an agar-diffusion method using Bacillus subtilis ATCC6633 as the test organism in nutrient agar containing 1 % sodium citrate. For the control, the buffer was used instead of enzyme solution. Binding was expressed as binding ratio (B), i.e. the ratio of drug in the free state to total drug concentration, calculated from the following equation.
B (%)=100 x(C0-Cb)/C0, where B was binding ratio, and Cb and Co were drug concentration in filtrate of the mixture with (Cb) and without enzyme (Co). Each preparation of ultrafiltrate was carried out within 30 minutes and below 4°C to minimize hydrolysis of drug, and was performed in duplicate. An enzyme concentration in which each agent showed half binding was obtained from binding-enzyme concentration curve.
Determination of Inactivation against the Cephalosporinase from C. freundii GN7391 The cephalosporinase from C. freundii GN7391 (97 nKat/ml: approx 2 //m, estimated by protein concentration and MW38,000) was incubated at 30°C with 2 /um of cephalosporin. Enzyme activity of the mixture was monitored during incubation using cephalothin as substrate, and wasexpressed in terms of percentage against activity of the mixture incubated without cephalosporin at same incubation time. Nocompetitive inhibition would be expected in the enzymeactivity assay, because the concentration of inhibitor in the assay reaction mixture was lowered below the level at which such inhibition would be detected, by 600-fold dilution with substrate solution. The assay was performed in duplicate.
Estimation of Hydrolysis Velocity
Velocity of hydrolysis at 0.1 jum of substrate was calculated from the following Michaelis-Menten
For cefotaxime, Kmvalues were assumed to be equal to Ki values. For the calculation of velocities at the cellular level, the amount and MWof the cephalosporinases from E. cloacae GN7471and C. freundii GN7391were taken to be 105 molecules per cell6), and 44,000 for E. cloacae1^and 38,000 for C. freundii17\
Results Hydrolysis by Cephalosporinases from E. cloacae GN7471
and C. /re««d// GN7391
To detect hydrolysis of BMY-28142,ceftazidime and cefotaxime, approximately 3,000 times (for the E. cloacae enzyme) or 1,000 times (for the C. freundii enzyme) more enzyme than that used in usual hydrolysis tests was used in this experiment. The initial hydrolysis velocities of BMY-28142,ceftazidime and cefotaxime at each series of initial substrate concentration by the enzyme from E. cloacae GN7471is shown in Fig. 1 . Hydrolysis rate-substrate concentration curves of the C. freundii enzyme were similar to those by the E. cloacae enzyme.
Hydrolysis velocity of BMY-28142and ceftazidime by these enzymes decreased significantly as substrate concentration decreased. No such reduction was seen with cefotaxime for both enzymes. BMY-28142was more hydrolyzable than cefotaxime and ceftazidime at 100^m, which is the con-centration commonlyused in hydrolysis test.
Km,Vmaxand Ki values were shownin Table 1 . The values were calculated from two or three experiments using one preparation of each enzyme. Ymaxof BMY-28142was about 6 times greater than that of ceftazidime for both enzymes, and was 15 times, for E. cloacae enzyme, or 120 times, for C. freundii enzyme, greater than that of cefotaxime.
Furthermore, the Kmvalue of BMY-28142was about 15 times, for E. cloacae enzyme, or 30 times, for C. freundii enzyme, greater than that of ceftazidime. For cefotaxime, the exact Kmvalues could not be obtained, because those values were far smaller than the substrate concentrations used. During the complete hydrolysis of 10^m of cefotaxime by the enzyme from E. cloacae GN7471, the hydrolysis velocity was constant until the substrate was exhausted. The sameobservation was obtained from complete hydrolysis of 3^m of cefotaxime by the enzyme from C.freundii GN7391. Ki of BMY-28142 was nearly one order of magnitude greater than that of ceftazidime and approximately four orders of magnitude greater than those of the other cephalosporins ( Reversible Inactivation with the Cephalosporinase from C. freundii GN7391
When cefotaxime and ceftazidime were mixed with approximately equimolar (2 /um) of the cephalosporinase from C. freundii GN7391, they showed inactivation of the enzyme, whereas BMY-28142did not (Fig. 2) . Ceftazidime needed a few minutes of incubation to show maximum inactivation. This inactivation was reversible, and the enzyme activity of the mixture with cefotaxime or ceftazidime was recovered during incubation. Under the same conditions, none of these cephalosporins showed significant inactivation of the cephalosporinase from E. cloacae GN7471. These results indicate that the inhibition of cefotaxime and ceftazidime against cephalosporinases of E. cloacae and C. freundii was not the inactivation such as inactivation by suicide substrates.
Estimation of Hydrolysis Velocity at LowConcentration The newer cephalosporins showvery low MICsagainst susceptible strains, and their concentration preventing activity of the targets (penicillin binding proteins (PBPs)) in periplasmic space is supposed as ca. 0.1^m10). For comparison of hydrolysis rates of these cephalosporins at cellular level, the velocities at 0.1 /^m substrates were estimated from the Michaelis-Menten equation, using Vmax and Km(Ki for cefotaxime) values (Table 2 ). At 0.1 /*m, the hydrolysis velocity of BMY-28142 was less than 0.07% of Vmax, which was smaller than that of cefotaxime or ceftazidime, while those of cefotaxime and ceftazidime were 54~90% of Vmax and 0.6~1.5 %of Vmax, respectively.
Decrease of Antibacterial Activity against E. coli omp Mutants by Production of Cephalosporinase of C. freundii
The effects of cephalosporinase production on the antibacterial activity of BMY-28142, ceftazidime, and cefotaxime against E. coli omp mutants was examined. The cephalosporinase activities of MC4100, MH1160, and MH760 carrying pMS185, which had cephalosporinase gene of C. freundii GN346, were 0.67-0.82 nKat/mg protein, whereas those of their host strains were not detected (less than 0.05 nKat/mg protein). Against E. coli MC4100, the parental strain, the MICof cefotaxime or ceftazidime was increased 4 to 8-fold by cephalosporinase production, whereas the MIC of BMY-28142 was unchanged (Table 3 ). In the case against MH1160, which lacks OmpFand C production, the effects of cephalosporinase were moreimpressive with Enzyme (approx 2 jum, 97 nKat/ml) was incubated at 30°C with 2 jum of BMY-28142 (O), ceftazidime (A), or cefotaxime (®).
Enzymeactivity of the mixture was monitored during the incubation, and was expressed in the terms of percentage against the activity of the mixture incubated without cephalosporins at same incubation time. b -f and -are with and without carrying pMS185which is a cloned plasmid having cephalosporinase gene of C. freundii GN346.
an increase in MIC was 16-fold for cefotaxime and ceftazidime and 4-fold for BMY-28142. Against MH760, which lacks OmpCand produces OmpFconstitutively, the increase in MIC of cefotaxime by cephalosporinase production was smaller than MC4100, while that of ceftazidime was as same as in MC4100. The MICs of BMY-28142 against MC4100 and MH760 were not affected by cephalosporinase production. These results indicate that ompmutation, which would decrease the outer membranepermeation rate of /3-lactams, would increase the effects of cephalosporinase on antimicrobial activity of cephalosporins including BMY-28142.
Discussion
BMY-28142 showed much lower affinity for cephalosporinases (i.e. high Kmand Ki) than cefotaxime and ceftazidime. This observation agrees with the finding of Phelps et al.9) , that the excellent antibacterial activity of BMY-28142originates in its low affinity for cephalosporinases. It is well known that some species of cephalosporinase-producing Gram-negative bacteria, such as E. cloacae, are less susceptible to cephalosporinase-stable^-lactams, e.g. cefotaxime, ceftazidime, etc.20 >2i:>. As to the mechanism of this resistance, there are controversial theories, in which affinity to cephalosporinase and very slow rate of hydrolysis are both considered9»21~23).
Hydrolysis reaction of /3-lactams by^-lactamases is expressed in the following equation20).
where E is enzyme (/3-lactamase), S is substrate (/3-lactam), ES is Michaelis complex, M is acyl intermediate, and P is product (inactivated /9-lactam). Wedetermined the hydrolysis rates of cephalosporinase-stable cephalosporins (Table 1) . Their Vmaxvalues were significantly smaller than that of cephalothin. Amongthese cephalosporins, BMY-28142 was most hydrolyzable at 100 jum. Therefore Vmaxof hydrolysis alone cannot explain the activity of BMY-28142.However, the hydrolytic velocity of BMY-28142decreased as the substrate concentration decreased, whereas that of cefotaxime did not (Fig. 1) . To evaluate the role of hydrolysis velocity on the resistance to cephalosporins which are poor substrate, we estimated the rate of hydrolysis at low substrate concentration (0.1 /^m). Although cefotaxime and ceftazidime possess inhibitory activity against cephalosporinases, the inhibition was not irreversible inactivation (Fig. 2) . Therefore it is reasonable to consider that Michaelis-Menten equation may be applicable to the hydrolysis reaction. Because the hydrolysis rate of cefotaxime did not decrease at the time whenthe substrate was almost exhausted, the Kmof cefotaxime was assumed to be equal to Ki in the estimation of hydrolysis rate of cefotaxime. From our estimation, the hydrolysis rate of BMY-28142at 0.1 jum was much lower than that of cefotaxime, and the difference in hydrolysis rate at 0.1 jum well explained the difference in antimicrobial activity between BMY-28142and cefotaxime. However, the rate of hydrolysis at 0.1 fiM could not explain the difference in activity between BMY-28142 and ceftazidime sufficiently, because the hydrolysis rate of ceftazidime at 0.1 jum was only 3 or 5 times greater than that of BMY-28142. On the other hand, we observed that presence of cephalosporinase decreased drug concentration in free state by binding. This binding might include both Michaelis complex (ES) and acyl intermediate (M) formation. Against the cephalosporinase from C. freundii, ceftazidime and cefotaxime showed reversible inactivation.
This might be formation of acyl intermediate (M) which had rather long half-life. "Trapping" or "sponge effects" may be reduction of free drug concentration in periplasmic space by formation of Mand/or ES complex which are the parts of hydrolysis reaction.
Because the hydrolysis rates of these cephalosporins was so slow, there needed consideration with permeation through outer membrane. Instead of direct comparison of hydrolysis rate with permeation rate, we determined the effects of cephalosporinase production on antimicrobial activity of the cephalosporins against E. coli omp mutants using a cloned plasmid carrying cephalosporinase gene of C. freundii. The permeation of cephalosporins through outer membrane has been considered to be simple diffusion through porin channels in outer membrane240. E. coli MH1160lacks OmpFand C, so the permeation rate of cephalosporins in MH1160may be lower than in E. coli MC4100which is a parent of MH1160.Because of constitutive production of OmpFin MH760,the permeation rate of cephalosporins may be rather higher than in MC4100.Whenthese strains produced cephalosporinase of C. freundii, susceptibility of these strains against cefotaxime, ceftazidime and BMY-28142 decreased. The effects of the cephalosporinase was most significant in MH1160, in which permeation rate might be lower than in MC4100.Decrease in susceptibility of MH760against cefotaxime was lower than that in MC4100, while the effect on susceptibility against ceftazidime was at same level in both MH760and MC4100. Antimicrobial activity of BMY-28142 was affected by the cephalosporinase only against MH1160. These results indicate that ceftazidime had rather lower permeability than cefotaxime or BMY-28142, and also indicate that outer membranepermeability might lead synergic effects with hydrolysis by cephalosporinase on the resistance to these cephalosporins.
On the difference in antimicrobial activity between BMY-28142and ceftazidime, there are two factors to be considered in addition to hydrolysis velocity. One is permeability through outer membrane discussed above. The other is affinity to PBPs. If ceftazidime needs rather higher concentration to inhibit PBPs than other cephalosporin does as discussed by Vu and Nikaido10) , hydrolysis rate of ceftazidime may increase proportional to it concentration. Thus the difference in antimicrobial activity between BMY-28142and ceftazidime may be explained by the synergic effects of the two factors and hydrolysis.
On the characteristics of^-lactams which activity is less affected by cephalosporinase production, there may be at least three types of agents. One is high stability against cephalosporinases at low concentration, that originates low affinity for the enzymes. BMY-28142possesses this characteristics. Another is high stability caused by high affinity for the enzymes and acyl intermediate formation that have very long half life. Latamoxef may be this type25). The other is high permeability through outer membranewhich would sufficiently reduce the effect of hydrolysis. Imipenemmaybe this type ofagent24).
In conclusion, both "non-hydrolytic barrier", i.e., "trapping" or "sponge effects", and "very slow hydrolysis" are the theories in which hydrolysis reaction is watched from each side. Because of low affinity for cephalosporinases, BMY-28142might be stable against the enzymes at low concentration still sufficient to inhibit the activity of PBPs. Therefore it showed excellent activity for cephalosporinase-producing bacteria.
